Att B1 - 60 day FRN

Federal Register / Vol. 76, No. 162 / Monday, August 22, 2011 / Notices
novel influenza viruses and biological
agents that pose a threat to global public
health. Through this international
collaboration ASPR will capitalize on
GMI’s influential position as an
important regional partner on disease
surveillance efforts and public health
emergency preparedness. This new
cooperative agreement will help to
further strengthen laboratory diagnostic
capacity in Panama and other countries
in the region. GMI’s strong collaborative
relationships with neighboring
governments, as well as its training
capabilities, and laboratory
infrastructure will be critical for the
viability of this partnership. In addition,
this collaboration will support overall
HHS efforts to continue building
capacity abroad with the ultimate intent
of detecting, stopping, slowing or
otherwise limiting the threat or actual
spread of bio-terrorism agents or a
pandemic to the United States, thereby
enhancing the health security of the
American population.
ADDITIONAL INFORMATION: The agency
program contact is Dr. Maria Julia
Marinissen, who can be contacted at
202–205–4214 or
Maria.Marinissen@hhs.gov.
Statutory Authority: Sections 301, 307,
1701 and 2811 of the Public Health Service
Act, 42 U.S.C. 241, 242l, 300u, 300hh–10.
Dated: August 15, 2011.
Nicole Lurie,
Assistant Secretary for Preparedness and
Response.
[FR Doc. 2011–21294 Filed 8–19–11; 8:45 am]
BILLING CODE 4150–37–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention

jlentini on DSK4TPTVN1PROD with NOTICES

Advisory Board on Radiation and
Worker Health: Notice of Charter
Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Board on Radiation and
Worker Health, Department of Health
and Human Services, has been renewed
for a 2-year period through August 3,
2013.
For information, contact Mr.
Theodore Katz, Designated Federal
Officer, Advisory Board on Radiation
and Worker Health, Department of
Health and Human Services, 1600
Clifton Road, M/S E20, Atlanta, Georgia
30341, telephone 404/498–2533, or fax
404/498–2570.

VerDate Mar<15>2010

18:50 Aug 19, 2011

Jkt 223001

The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: August 12, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2011–21413 Filed 8–19–11; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–11–11KA]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Catina Conner, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Use of Evidence-Based Practices for
Comprehensive Cancer Control—New—
National Center for Chronic Disease

PO 00000

Frm 00027

Fmt 4703

Sfmt 4703

52329

Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
There have been increasing calls in
the fields of public health generally and
cancer control specifically for the
dissemination, adoption, and
implementation of evidence-based
practices (EBPs). EBPs are public health
practices (interventions, programs,
strategies, policies, procedures,
processes, and/or activities) that have
been tested or evaluated and shown to
be effective. However, while the
development, review, and compilation
of EBPs has steadily increased over
time, there is concern that the adoption
and implementation of those practices,
including among cancer control
planners and practitioners, has not kept
pace. Given the gap between the
development of EBPs and their use,
public health and cancer control
organizations need to place greater
emphasis on the promotion and
dissemination of these practices among
those who can use them to improve
population health.
While efforts to promote cancer
control EBPs have increased, questions
remain whether these efforts will result
in widespread adoption and
implementation of EBPs in the context
of comprehensive cancer control (CCC)
in the states, Tribes, and U.S.
Associated Pacific Island Jurisdictions
and territories. National Comprehensive
Cancer Control Program (NCCCP)
grantees may face a number of
challenges to incorporating EBPs into
CCC efforts in their jurisdictions. In
order to address these barriers
effectively and better promote the use of
EBPs for cancer control, CDC would like
to understand (1) how evidence-based
approaches are currently being used to
develop CCC plans; (2) how CCC
programs identify EBPs; (3) what EBPs
have been adopted by CCC programs;
and (4) what challenges and unintended
consequences have been encountered in
their implementation.
CDC plans to conduct a new, one-time
study to examine CCC planners’ use of
scientific and practice-based
information to inform development of
their CCC plans. Information collection
will consist of two Web-based surveys
involving key CCC stakeholders in the
NCCCP-funded states, Tribes, and U.S.
Associated Pacific Island Jurisdictions
and territories. Respondents for the first
survey will be Directors of the 66
NCCCP-funded programs, who will also
have the opportunity to participate in a
follow-up telephone call. Respondents
for the second survey will be key

E:\FR\FM\22AUN1.SGM

22AUN1

52330

Federal Register / Vol. 76, No. 162 / Monday, August 22, 2011 / Notices

program partners/collaborators
identified by each Program Director (1–
2 partners per Director) as instrumental
to the selection and implementation of
cancer control EBPs. The survey results
will help CDC enhance existing NCCCP
efforts by identifying new strategies for
promoting the use of evidence-based
approaches to comprehensive cancer
control. The surveys will also identify

future studies. CDC’s authorization to
conduct the study is provided by
Section 301 of the Public Health Service
Act (42 U.S.C. 241).
OMB approval will be requested for
one year. Participation in the study is
voluntary. There are no costs to the
respondents other than their time.

technical assistance needs of NCCCPfunded awardees related to selection
and implementation of EBPs, and will
contribute to CDC’s efforts to build the
capacities of states, Tribes, and Pacific
Island Jurisdictions and territories
toward more effective efforts in cancer
prevention and control. Finally, the
results may lead to new insights and
questions that can be addressed in

ESTIMATED ANNUALIZED BURDEN HOURS
Type of Respondent

Form name

CCC Program Directors ...........

Survey Scheduling Script .........................
Program Directors Web Survey Questionnaire.
Program Directors Telephone Interview
Guide and Script.
Program Partners Web Survey Questionnaire.

CCC Program Partners ............
Total ..........................................

...................................................................

Catina Conner,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–21400 Filed 8–19–11; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review

jlentini on DSK4TPTVN1PROD with NOTICES

The meeting announced below
concerns Member Conflict Review,
Program Announcement (PA) 07–318,
initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 1 p.m.–3 p.m., November
9, 2011 (Closed).
Place: National Institute for Occupational
Safety and Health (NIOSH), CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26506, Telephone: (304) 285–6143.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Member Conflict Review, PA
07–318.’’

VerDate Mar<15>2010

18:50 Aug 19, 2011

Jkt 223001

Number of responses per
respondent

66
66

1
1

15/60
0.5

17
33

66

1

20/60

22

132

1

0.5

66

........................

........................

........................

138

Contact Person for More Information:
Bernadine Kuchinski, PhD, Scientific Review
Officer, Office of Extramural Programs,
NIOSH, CDC, Robert A. Taft Laboratories,
4676 Columbia Parkway, MS C–7, Cincinnati,
Ohio 45226, Telephone: (513) 533–8511.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: August 12, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2011–21420 Filed 8–19–11; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Safety and Occupational Health Study
Section (SOHSS), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
8 a.m.–5 p.m., October 18, 2011 (Closed).
8 a.m.–5 p.m., October 19, 2011 (Closed).

PO 00000

Frm 00028

Fmt 4703

Average burden per response
(in hours)

Number of respondents

Sfmt 4703

Total response
burden
(in hours)

Place: Embassy Suites, 1900 Diagonal
Road, Alexandria, Virginia 22314,
Telephone: (703) 684–5900, Fax: (703) 684–
0653.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and the
Determination of the Director, Management
Analysis and Services Office, CDC, pursuant
to Public Law 92–463.
Purpose: The Safety and Occupational
Health Study Section will review, discuss,
and evaluate grant application(s) received in
response to the Institute’s standard grants
review and funding cycles pertaining to
research issues in occupational safety and
health, and allied areas.
It is the intent of NIOSH to support broadbased research endeavors in keeping with the
Institute’s program goals. This will lead to
improved understanding and appreciation for
the magnitude of the aggregate health burden
associated with occupational injuries and
illnesses, as well as to support more focused
research projects, which will lead to
improvements in the delivery of occupational
safety and health services, and the
prevention of work-related injury and illness.
It is anticipated that research funded will
promote these program goals.
Matters To Be Discussed: The meeting will
convene to address matters related to the
conduct of Study Section business and for
the study section to consider safety and
occupational health-related grant
applications.
These portions of the meeting will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5 U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention, pursuant to Section 10(d)
Pub. L. 92–463.

E:\FR\FM\22AUN1.SGM

22AUN1